Home Moneycontrol Business News Expect steady growth in biosimilars segment going forward, says Kiran Mazumdar Shaw of Biocon

Expect steady growth in biosimilars segment going forward, says Kiran Mazumdar Shaw of Biocon

00:01

Expect steady growth in biosimilars segment going forward, says Kiran Mazumdar Shaw of Biocon

â€œOverall, we have a nice basket of biosimilars for both the US and European market, which will set us up for a steady growth in that segment going forward,â€ said Shaw.

from Moneycontrol Business News https://ift.tt/2D6iQRX

Subscribe to: Post Comments ( Atom )

Recent
Popular
Comments